Venetoclax is a potent, selective BCL-2 inhibitor. It blocks BCL-2/BIM binding by locking the BH3 groove to trigger apoptosis.
Venetoclax (ABT-199) IC50 for Cell-based and Cell-free Assays
Jump to:
- Venetoclax (ABT-199) Mechanism of Action: BCL-2 Inhibition in Myeloblast Research
- Venetoclax (ABT-199) Working Concentration | Cell Culture | Treatment
- Venetoclax (ABT-199) Solubility in DMSO
- Venetoclax (ABT-199) Storage & Stability
- Venetoclax (ABT-199) VS Navitoclax (ABT-263) | ABT-737
- Venetoclax (ABT-199) Molecular Weight | Chemical Structure | Stock Solution
- Venetoclax (ABT-199) TargetMol (T2119)? Try a better option.
- Venetoclax (ABT-199) MCE (HY-15531)? Try a better option.
- Venetoclax (ABT-199) Abcam (ab217298)? Try a better option.
- Venetoclax (ABT-199) Cayman (16233)? Try a better option.
- Venetoclax (ABT-199) Tocris (6960)? Try a better option.
- ABT-199 (Venetoclax) SDS｜MSDS
- Venetoclax (ABT-199) in Acute Myeloid Leukemia
- Venetoclax (ABT-199) in Chronic Lymphocytic Leukemia
- Venetoclax (ABT-199) in Non-Hodgkin Lymphoma